Neonatal Neurology 4: Neurodevelopment

Moderator(s)

• 

  Amr El Shahed, Staff Neonatologist (he/him/his)

  Assistant Professor of Pediatrics
  University of Toronto Temerty Faculty of Medicine
  Toronto, Ontario, Canada
• TD

  Tara DuPont, MD (she/her/hers)

  Associate professor
  University of Utah School of Medicine
  Salt Lake City, Utah, United States

Presentations:

• 2:00 PM – 2:15 PM ET

  In utero SSRI exposure alters fetal cerebral cortical development and structural brain connectivity
  

  Presenting Author: Josepheen De Asis-Cruz, MD, PhD (she/her/hers) – Children's National Health System
• 2:15 PM – 2:30 PM ET

  Updated, Severity-based Bronchopulmonary Dysplasia Definition and Neurodevelopmental Outcomes at 18-22 months’ corrected age
  

  Presenting Author: Mireille Guillot, MD, MSc, FRCPC (she/her/hers) – Faculty of Medicine Université Laval
• 2:30 PM – 2:45 PM ET

  Neurodevelopmental outcomes and mortality after IVH grade 3-4: a population matched cohort study
  

  Presenting Author: Philippa Rees, BSc (Hons) MPhil MBBCh MRCPCH – UCL Institute of Child Health
• 2:45 PM – 3:00 PM ET

  Cerebellar GABA and Glutamate Concentrations at Term-equivalent age Predicts 18-month Cognitive Deficits in Preterm Infants
  

  Presenting Author: Sudeepta K. Basu, MD (he/him/his) – Children's National Health System
• 3:00 PM – 3:15 PM ET

  Morphine Exposure in the NICU in Relation to Thalamic Volume and Autism Spectrum Symptoms at Age 8 Years in Children Born Very Preterm
  

  Presenting Author: Cecil M Y Chau (he/him/his) – University of British Columbia Faculty of Medicine
• 3:15 PM – 3:30 PM ET

  Neurodevelopmental outcomes prediction in newborns with seizures caused by KCNQ2 gene defects
  

  Presenting Author: Zhelan Huang, PhD (she/her/hers) – Children’s Hospital of Fudan University